Skip to main content
    Information
    information_group_1
    Type of settings
    On-line
    Category of capacity building activity
    Seminar/Webinar
    PHIRI Activity
    No
    Activity schedule
    Fixed date(s)
    information_group_dates
    Activity local date
    -
    information_group_2
    GEO coverage
    Multinational
    Language
    English
    Available in other languages
    No
    Target audience
    Junior specialists;
    Experts;
    Public Health Sector;
    Public Health Professionals;
    Public Health Authorities

    In continuation to the scientific discussions on COVID-19 vaccines research, WHO R&D Blueprint organized a follow-up consultation to review emerging data related to the omicron variant. During this forthcoming consultation global experts reviewed the available evidence, critically appraised the data, and summarized the interpretation of evidence and next steps.

    Topics
    Health status » Morbidity/disability » Communicable diseases » Covid-19;
    Health systems » Health system performance » Quality » Vaccination coverage;
    Policy » Response Plan
    organization_group
    Leading organizer
    World Health Organisation
    Contact

    WHO Headquarters in Geneva

    Telephone: +41 22 791 21 11 | Website (link in here)

    Updated on 28 April 2022